Scholar Rock Holding Corp (SRRK) - Total Assets
Based on the latest financial reports, Scholar Rock Holding Corp (SRRK) holds total assets worth $411.72 Million USD as of September 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Scholar Rock Holding Corp - Total Assets Trend (2016–2024)
This chart illustrates how Scholar Rock Holding Corp's total assets have evolved over time, based on quarterly financial data. Also see market cap of Scholar Rock Holding Corp for the company's overall valuation and market capitalisation.
Scholar Rock Holding Corp - Asset Composition Analysis
Current Asset Composition (December 2024)
Scholar Rock Holding Corp's total assets of $411.72 Million consist of 95.0% current assets and 5.0% non-current assets. Review Scholar Rock Holding Corp balance sheet liabilities to assess the company's total debt and financial obligations.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 37.5% |
| Accounts Receivable | $2.15 Million | 0.5% |
| Inventory | $0.00 | 0.0% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $2.40 Million | 0.5% |
| Goodwill | $0.00 | 0.0% |
Asset Composition Trend (2016–2024)
This chart illustrates how Scholar Rock Holding Corp's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. See SRRK stock price and chart for real-time trading data and today's change.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Scholar Rock Holding Corp's current assets represent 95.0% of total assets in 2024, an increase from 86.9% in 2016.
- Cash Position: Cash and equivalents constituted 37.5% of total assets in 2024, up from 30.6% in 2016.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 2016.
- Asset Diversification: The largest asset category is intangible assets at 0.5% of total assets.
Scholar Rock Holding Corp Competitors by Total Assets
Key competitors of Scholar Rock Holding Corp based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
CSL Ltd
AU:CSL
|
Australia | AU$39.54 Billion |
|
Vaxcyte Inc
NASDAQ:PCVX
|
USA | $3.14 Billion |
|
Bachem Holding AG
SW:BANB
|
Switzerland | CHF2.11 Billion |
|
Definium Therapeutics, Inc.
NASDAQ:DFTX
|
USA | $1.11 Billion |
|
Chongqing Zhifei Bio Products
SHE:300122
|
China | CN¥29.09 Billion |
|
HLB Co. Ltd
KQ:028300
|
Korea | ₩925.44 Billion |
|
Sinopep-Allsino Biopharmaceutical Co. Ltd. A
SHG:688076
|
China | CN¥6.82 Billion |
|
Zhejiang Ausun Pharmaceutical Co Ltd
SHG:603229
|
China | CN¥3.16 Billion |
Scholar Rock Holding Corp - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 6.30 | 3.88 | 8.09 |
| Quick Ratio | 6.30 | 3.88 | 8.09 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $328.74 Million | $113.56 Million | $301.84 Million |
Scholar Rock Holding Corp - Advanced Valuation Insights
This section examines the relationship between Scholar Rock Holding Corp's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 19.43 |
| Latest Market Cap to Assets Ratio | 9.88 |
| Asset Growth Rate (YoY) | 52.7% |
| Total Assets | $474.92 Million |
| Market Capitalization | $4.69 Billion USD |
Valuation Analysis
Premium Asset Valuation: The market values Scholar Rock Holding Corp's assets at a significant premium (9.88x), suggesting investors see substantial growth potential or unique competitive advantages.
Rapid Asset Growth: Scholar Rock Holding Corp's assets grew by 52.7% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for Scholar Rock Holding Corp (2016–2024)
The table below shows the annual total assets of Scholar Rock Holding Corp from 2016 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | $474.92 Million | +52.69% |
| 2023-12-31 | $311.04 Million | -13.16% |
| 2022-12-31 | $358.17 Million | +17.65% |
| 2021-12-31 | $304.44 Million | -21.60% |
| 2020-12-31 | $388.31 Million | +97.73% |
| 2019-12-31 | $196.38 Million | +8.30% |
| 2018-12-31 | $181.34 Million | +194.20% |
| 2017-12-31 | $61.64 Million | +88.02% |
| 2016-12-31 | $32.78 Million | -- |
About Scholar Rock Holding Corp
Scholar Rock Holding Corporation, a biopharmaceutical company, focuses on the discovery, development, and delivery of medicines for the treatment of serious diseases in which signaling by protein growth factors plays a fundamental role. Its transforming growth factor beta (TGFß) superfamily biology, its novel understanding of the molecular mechanisms of growth factor activation enabled us to deve… Read more